FDA proposes tighter rules on panelists
The Food and Drug Administration recently proposed tightening rules to minimize conflicts of interest among outside medical experts serving on agency advisory committees. The panels are extremely important because the FDA tends to follow their recommendations on key matters such as drug approval and emerging safety questions.
For the full article.
Bookmark: 
